期刊文献+

实施临床路径对2型糖尿病患者影响的研究

The Research of Influence on Patients that Perform Clinical Pathway with Type 2 Diabetes
原文传递
导出
摘要 目的:探讨实施临床路径后对2型糖尿病患者的影响。方法:选择某三甲医院2011年前未实施临床路径和2011年实施临床路径后诊断为2型糖尿病的患者,观察比较实施临床路径前后2型糖尿病患者的平均住院日、再住院率、住院费用、药费、耗材费、检查费以及2型糖尿病治愈、好转、死亡等效果等指标有无差异。结果:实施临床路径前后2型糖尿病患者的平均住院日、再住院率、住院费用、药费、耗材费、检查费以及2型糖尿病治愈、好转、死亡等效果相比较有明显差异(P<0.01)。结论:2型糖尿病人治疗中实施临床路径可显著缩短平均住院日,降低平均住院费、药费、耗材费及检查费用,再住院率明显降低,实施临床路径后2型糖尿病治愈、好转、死亡等效果比实施临床路径前明显改善。临床路径的开展和应用,使患者在最合适的时机得到最合理的检测、诊断和治疗,大大优化医疗资源,改善治疗结局,具有临床应用价值,值得临床推广和应用。 Objective: To investigate the effect of the clinical pathway on patients with type 2 diabetes mellitus. Methods: The patients with type 2 diabetes patients without implemented the clinical pathway before and performed the clinical pathway in 2011 were chosen, then the difference in average day in hospital, hospital admission rates again, hospital cost, expenses for medicine, material fee, examination fee and type 2 diabetes cure rate, improvement, death were detectedq. Results: After perform the clinical pathway on patients with type 2 diabetes, the average day in hospital, hospital admission rates again, hospital cost, expenses for medicine, material fee, examination fee and type 2 diabetes cure rate, improvement, death effects had obvious difference (P〈0.01). Conclusion: Perform clinical pathway on patients with type 2 diabetes can significantly shorten the average day in hospital, reduce the average hospitalization expenses, expenses for medicine, material fee and checking expenses, and the hospitalization rate was reduced significantly. The development and application of clinical pathway can optimize medical resources, improve the treatment outcome, with a great clinical application value.
出处 《现代生物医学进展》 CAS 2014年第8期1518-1521,共4页 Progress in Modern Biomedicine
关键词 2型糖尿病 临床路径 影响 Type 2 diabetes Clinical pathway Influence
  • 引文网络
  • 相关文献

参考文献21

  • 1糖尿病防控评估研究小组.中国糖尿病防控蓝皮书[M].华中科技大学同济医学院,2011.
  • 2Yang W, Lu J, Weng J, et al. Prevalence of Diabetes among Men and Women in China [J]. New England Journal of Medicine, 2010,362: 1090-1101.
  • 3Cheah TS. The Impact of Clinical Guidelines and Clinical Pathways on Medical Practice: Effectiveness and Medico-legal Aspects [J]. Annals Academy of Medicine,1998,27(4):532-539.
  • 4Feldstein P J, Wickizer TM, Wheeler JR. Private cost containment. The effects of utilization review programs on health care use and expenditttres [J]. New England Journal of Medicine, 1988, 318: 1310-1314.
  • 5Kampan P. Comparison of outcomes of treatment in non-insulin dependent diabetics between OPD and DM clinic at Taksin Hospital [J]. Taksin Medical Jottrnal, 1997, 15:38-47.
  • 6Nagata Y, Masuda A, Suzuki Y. Impact of a Clinical Pathway in Cases of Transurethral Resection of the Prostate [J]. Tokai Journal of Experimental Clinical Medecine, 2007,32(2):54-58.
  • 7Weingarten S, Riedinger MS, Sandle M, et al. Can practice guidelines safely reduce hospital length of stay? Results from a multicenter interventional study [J]. American Journal of Medicine,1998,105: 33-40.
  • 8Pearson SD, Goulart F D, Lee TH. Critical pathways as a strategy for improving care: problems and potential [J]. Annals of International Medicine, 1995,123:941-948.
  • 9曹永斌.实施临床路径的现实意义[J].中国病案,2010,11(9):28-29. 被引量:19
  • 10任卫东,由兰兰,许峥嵘,谷君,李明霞,史丽.对2型糖尿病住院病人应用临床路径管理的效果评价[J].河北北方学院学报(自然科学版),2011,27(5):89-90. 被引量:6

二级参考文献41

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部